Home › Research › Disparities
Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults
Collyer TA, Murray AM, Woods RL, Storey E, Chong TT, Ryan J, Orchard SG, Brodtmann A et al.. JAMA network open, 2022-05-02
Topic: Risk, prevention and care in population studies
Plain-language summary
Importance Dual decline in gait speed and cognition has been found to be associated with increased dementia risk in previous studies. Results Of 19 114 randomized participants, 16 855 (88.2%) had longitudinal gait and cognitive data for inclusion in this study (mean [SD] age, 75.0 [4.4] years; 9435 women [56.0%], 7558 participants [44.8%] with 12 or more years of education). Compared with nondecliners, risk of dementia was highest in the gait plus HVLT-R decliners (hazard ratio [HR], 24.7; 95% CI, 16.3-37.3), followed by the gait plus 3MS (HR, 22.2; 95% CI, 15.0-32.9), gait plus COWAT-F (HR, 4.7; 95% CI, 3.5-6.3), and gait plus SDMT (HR, 4.3; 95% CI, 3.2-5.8) groups. Dual decliners had a higher risk of dementia than those with either gait or cognitive decline alone for 3MS and HVLT-R. These findings support the inclusion of gait speed in dementia risk screening assessments.
What this study adds
Evidence grade: High
This is a follow-up (cohort) study of 7,558 participants. Older adults who declined in both gait speed and cognition had a much higher risk of later dementia than those who did not decline. Reported effect size: 88.2%; 56.0%; 44.8%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Collyer, T. A., Murray, A. M., Woods, R. L., Storey, E., Chong, T. T., Ryan, J., et al. (2022). Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2022.14647
Vancouver
Collyer TA, Murray AM, Woods RL, Storey E, Chong TT, Ryan J, et al. Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults. JAMA network open. 2022. doi:10.1001/jamanetworkopen.2022.14647. PMID: 35639376.
BibTeX
@article{collyer2022-35639376,
author = {Collyer, T. A. and Murray, A. M. and Woods, R. L. and Storey, E. and Chong, T. T. and Ryan, J. and Orchard, S. G. and Brodtmann, A. and others},
title = {{Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults}},
journal = {JAMA network open},
year = {2022},
doi = {10.1001/jamanetworkopen.2022.14647},
pmid = {35639376},
url = {https://doi.org/10.1001/jamanetworkopen.2022.14647}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Importance Dual decline in gait speed and cognition has been found to be associated with increased dementia risk in previous studies.
- Results Of 19 114 randomized participants, 16 855 (88.2%) had longitudinal gait and cognitive data for inclusion in this study (mean [SD] age, 75.0 [4.4] years; 9435 women [56.0%], 7558 participants [44.8%] with 12 or more years of education).
- Compared with nondecliners, risk of dementia was highest in the gait plus HVLT-R decliners (hazard ratio [HR], 24.7; 95% CI, 16.3-37.3), followed by the gait plus 3MS (HR, 22.2; 95% CI, 15.0-32.9), gait plus COWAT-F (HR, 4.7; 95% CI, 3.5-6.3), and gait plus SDMT (HR, 4.3; 95% CI, 3.2-5.8) groups.
- Dual decliners had a higher risk of dementia than those with either gait or cognitive decline alone for 3MS and HVLT-R.
- These findings support the inclusion of gait speed in dementia risk screening assessments.
Why it matters
Older adults who declined in both gait speed and cognition had a much higher risk of later dementia than those who did not decline. The authors say gait speed should be included in dementia risk screening, but this is about predicting risk, not treating, curing, or preventing dementia.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Study designcohort study
- Participants7,558
- Effect size88.2%; 56.0%; 44.8%
- Evidence strengthHigh
How this study scored 78/100
Published in a leading specialty journal, and it is a randomized controlled trial.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA network open) |
| Journal's citation record | 2 / 4 | JAMA Network Open: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial (from PubMed type “Randomized Controlled Trial”) |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 3 / 4 | 7,558 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 1 / 2 | Randomized (as stated in the record) |
| Times cited | 5 / 7 | Cited 135 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 22.5 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 4 / 6 | Cited 15.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 3 / 4 | Cited 110 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Michele L. Callisaya: h-index 47 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Minnesota: institution h-index 1,568 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35639376) |
| Free to read | 2 / 2 | Free to read |
| Total | 78 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamanetworkopen.2022.14647
- PubMed: 35639376
- Original source →
- Free full text: JAMA Network Open →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in Disparities from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.